All News

The investigational, live biotherapeutic demonstrated superior efficacy vs placebo in reduction of recurrent Clostridioides difficile infection in ~100 patients at 8-week follow-up.

The CDC released the first set of new STI guidelines since 2015. What are the notable updates that primary care physicians should know? Find out here.

Schaffner, medical director of the National Foundation for Infectious Disease, says we need to re-educate on the dangers of flu and "sell" the influenza vaccine to the vaccine-fatigued.

Who needs a flu shot and when is not always straightforward. This year it's more important than ever to know what the CDC recommends. Start with 3 short scenarios.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Incoming AAFP president Ransone is clear that this year's flu season will be hard on all front line clinicians. In this short video, he talks about AAFP members' greatest concerns.

There is a very small risk of myocarditis after the second dose of COVID-19 mRNA vaccines. How small? And how small vs the risks associated with infection?

Test what you know about flu seasons past and what the flu season present might have in store with 8 questions based on the history. Remember: Winter is coming.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Aggressive control of systolic BP in adults aged 60 to 80 years significantly reduced CV risk, adding to evidence from the pivotal SPRINT trial in support of tight BP control.

Substituting regular salt with low-sodium alternative was found to reduce the risk of stroke, major cardiovascular events, and death in a new study presented at ESC Congress 2021.

There is something new with the flu and the vaccine against it every year. We summarized answers to 10 questions frequently asked by patients and clinicians alike.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Finerenone, in patients with mild-to-moderate renal disease and T2D, reduced CV event risk by 13% and risk for a composite renal event by 23%, study authors reported at ESC 2021.

Why wouldn't a person with severe obesity want to talk about bariatric surgery? Why wouldn't the patient's physician want to do it? The reasons for hesitation are many.

In a pooled analysis of 2 key clinical trials, empagliflozin was beneficial in patients with heart failure with a reduced and preserved ejection fraction.

Empagliflozin in patients with HFpEF reduced by 21% the risk of cardiovascular death or heart failure hospitalization across all prespecified subgroups, including those with/without diabetes.

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.